These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
606 related items for PubMed ID: 11406558
1. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells. Singal R, van Wert J, Bashambu M. Cancer Res; 2001 Jun 15; 61(12):4820-6. PubMed ID: 11406558 [Abstract] [Full Text] [Related]
2. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. Lin X, Asgari K, Putzi MJ, Gage WR, Yu X, Cornblatt BS, Kumar A, Piantadosi S, DeWeese TL, De Marzo AM, Nelson WG. Cancer Res; 2001 Dec 15; 61(24):8611-6. PubMed ID: 11751372 [Abstract] [Full Text] [Related]
3. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. Wang LG, Beklemisheva A, Liu XM, Ferrari AC, Feng J, Chiao JW. Mol Carcinog; 2007 Jan 15; 46(1):24-31. PubMed ID: 16921492 [Abstract] [Full Text] [Related]
5. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells. Lin X, Nelson WG. Cancer Res; 2003 Jan 15; 63(2):498-504. PubMed ID: 12543808 [Abstract] [Full Text] [Related]
6. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ. Oncogene; 2002 Feb 07; 21(7):1048-61. PubMed ID: 11850822 [Abstract] [Full Text] [Related]
7. Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines. Karius T, Schnekenburger M, Ghelfi J, Walter J, Dicato M, Diederich M. Biochem Pharmacol; 2011 Jun 01; 81(11):1329-42. PubMed ID: 21453686 [Abstract] [Full Text] [Related]
8. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer. Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL, Clark SJ. Oncogene; 1999 Feb 11; 18(6):1313-24. PubMed ID: 10022813 [Abstract] [Full Text] [Related]
9. Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. Nelson CP, Kidd LC, Sauvageot J, Isaacs WB, De Marzo AM, Groopman JD, Nelson WG, Kensler TW. Cancer Res; 2001 Jan 01; 61(1):103-9. PubMed ID: 11196146 [Abstract] [Full Text] [Related]
10. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Zhang Y, Fatima N, Dufau ML. Mol Cell Biol; 2005 Sep 01; 25(18):7929-39. PubMed ID: 16135786 [Abstract] [Full Text] [Related]
11. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ. Clin Cancer Res; 2002 Apr 01; 8(4):1087-92. PubMed ID: 11948118 [Abstract] [Full Text] [Related]
12. Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Das PM, Ramachandran K, Vanwert J, Ferdinand L, Gopisetty G, Reis IM, Singal R. Mol Cancer; 2006 Jul 18; 5():28. PubMed ID: 16848908 [Abstract] [Full Text] [Related]
13. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration. Bhakat KK, Mitra S. Carcinogenesis; 2003 Aug 18; 24(8):1337-45. PubMed ID: 12807730 [Abstract] [Full Text] [Related]
14. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Pulukuri SM, Rao JS. Oncogene; 2006 Aug 03; 25(33):4559-72. PubMed ID: 16786000 [Abstract] [Full Text] [Related]
15. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells. Liu Z, Marquez M, Nilsson S, Holmberg AR. Oncol Rep; 2008 Jul 03; 20(1):151-4. PubMed ID: 18575731 [Abstract] [Full Text] [Related]
16. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. Konduri SD, Srivenugopal KS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Ali-Osman F, Kondraganti S, Lakka SS, Rao JS. Oncogene; 2003 Jul 17; 22(29):4509-16. PubMed ID: 12881707 [Abstract] [Full Text] [Related]
17. Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells. Bakker J, Lin X, Nelson WG. J Biol Chem; 2002 Jun 21; 277(25):22573-80. PubMed ID: 11960994 [Abstract] [Full Text] [Related]
18. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Jerónimo C, Varzim G, Henrique R, Oliveira J, Bento MJ, Silva C, Lopes C, Sidransky D. Cancer Epidemiol Biomarkers Prev; 2002 May 21; 11(5):445-50. PubMed ID: 12010858 [Abstract] [Full Text] [Related]
19. Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression. Claus R, Fliegauf M, Stock M, Duque JA, Kolanczyk M, Lübbert M. J Leukoc Biol; 2006 Dec 21; 80(6):1462-72. PubMed ID: 17000900 [Abstract] [Full Text] [Related]
20. Glutathione-S-transferase pi 1(GSTP1) gene silencing in prostate cancer cells is reversed by the histone deacetylase inhibitor depsipeptide. Hauptstock V, Kuriakose S, Schmidt D, Düster R, Müller SC, von Ruecker A, Ellinger J. Biochem Biophys Res Commun; 2011 Sep 09; 412(4):606-11. PubMed ID: 21855532 [Abstract] [Full Text] [Related] Page: [Next] [New Search]